ARCHIVES

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Study: Delaying ADT Until Symptoms Appear Can Be Safe in Men with a PSA-based Relapse

May 30, 2014

AACR Calls For Clear Statement; Says Report Was “Premature”

February 14, 1997

IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel

November 26, 1999

FDA Advisors Okay DDC For AIDS Treatment In Comb With AZT

May 8, 1992

Haller Named Editor-In-Chief Of JCO; White House Appoints Duffy To NCAB.

March 17, 2000

NIH wins A-76 competition for extramural support services.

September 26, 2003